Loading...

OraSure Technologies, Inc.

OSURNASDAQ
Healthcare
Medical - Instruments & Supplies
$3.00
$0.14(4.90%)

OraSure Technologies, Inc. (OSUR) Financial Performance & Income Statement Overview

Review OraSure Technologies, Inc. (OSUR) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-54.17%
54.17%
Operating Income Growth
-186.43%
186.43%
Net Income Growth
-136.34%
136.34%
Operating Cash Flow Growth
-80.67%
80.67%
Operating Margin
-93.56%
93.56%
Gross Margin
111.69%
111.69%
Net Profit Margin
-131.96%
131.96%
ROE
-12.66%
12.66%
ROIC
86.35%
86.35%

OraSure Technologies, Inc. (OSUR) Income Statement & Financial Overview

Analyze OraSure Technologies, Inc.’s OSUR earnings with segmented quarterly and yearly financial statement figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$934000.00$37.45M$264000.00$54.34M
Cost of Revenue-$11.37M$23.88M-$16.81M$28.76M
Gross Profit$12.30M$12.45M$17.07M$25.58M
Gross Profit Ratio$13.17$0.33$64.66$0.47
R&D Expenses$9.60M$6.09M$5.62M$6.12M
SG&A Expenses$20.96M$19.90M$17.45M$19.78M
Operating Expenses$30.56M$25.98M$23.07M$25.61M
Total Costs & Expenses$19.20M$49.86M$6.26M$54.37M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$0.00$2.50M$0.00$2.61M
EBITDA-$18.27M-$9.92M-$6.00M$826000.00
EBITDA Ratio-$19.56-$0.26-$22.72$0.02
Operating Income-$18.27M-$12.42M-$6.00M-$34000.00
Operating Income Ratio-$19.56-$0.33-$22.72-$0.001
Other Income/Expenses (Net)$2.29M$2.91M$2.78M$3.07M
Income Before Tax-$15.97M-$9.51M-$3.22M$326000.00
Income Before Tax Ratio-$17.10-$0.25-$12.19$0.006
Income Tax Expense$68000.00$758000.00$678000.00$381000.00
Net Income-$16.04M-$10.79M-$4.51M-$615000.00
Net Income Ratio-$17.17-$0.29-$17.07-$0.01
EPS-$0.21-$0.00-$0.06-$0.008
Diluted EPS-$0.21-$0.00-$0.06-$0.008
Weighted Avg Shares Outstanding$74.87M$74.43M$74.58M$74.16M
Weighted Avg Shares Outstanding (Diluted)$74.87M$74.43M$74.58M$74.16M

Over the past four quarters, OraSure Technologies, Inc. demonstrated steady revenue growth, increasing from $54.34M in Q2 2024 to $934000.00 in Q1 2025. Operating income reached -$18.27M in Q1 2025, maintaining a consistent -1956% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$18.27M, reflecting operational efficiency. Net income dropped to -$16.04M, with EPS at -$0.21. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;